Related Experiment Video
Updated: Jul 14, 2026

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study
A Gerdelat-Mas1, M Simonetta-Moreau, C Thalamas
1Fédération de Neuroscience, Hôpital Purpan, Toulouse, France. gerdelat-mas.a@chu-toulouse.fr
Levodopa treatment improved objective pain thresholds in Parkinson's disease (PD) patients, suggesting dopaminergic pathways modulate pain perception. PD patients exhibited lower pain thresholds compared to healthy individuals.
Area of Science:
- Neuroscience
- Pain Research
- Neurology
Background:
- Parkinson's disease (PD) patients report pain potentially linked to neuropathic pain.
- Basal ganglia and dopaminergic pathways are implicated in central pain processing.
Purpose of the Study:
- To evaluate levodopa's effect on objective pain thresholds in PD patients versus healthy subjects.
- To compare pain perception differences between PD patients and controls.
Main Methods:
- Assessed objective pain threshold using the nociceptive flexion reflex (RIII).
- Studied 13 PD patients and 10 healthy controls under levodopa (ON) and no levodopa (OFF) conditions.
Main Results:
- Levodopa significantly raised the RIII threshold in PD patients (OFF vs. ON).
- PD patients showed a lower RIII threshold than controls when not on levodopa (OFF).
- Levodopa did not alter RIII threshold in healthy subjects.
Conclusions:
- Demonstrates dopaminergic modulation of objective pain threshold in Parkinson's disease.
- Confirms objective pain perception disturbances in PD patients, evidenced by lower thresholds off levodopa.
More Related Videos
06:04Objective Nociceptive Assessment in Ventilated ICU Patients: A Feasibility Study Using Pupillometry and the Nociceptive Flexion Reflex
Published on: July 4, 2018
06:45Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Analgesia and Pain Management